A company has a $200M deferred tax asset from NOL carryforwards with a full valuation allowance of $200M (net DTA zero). It records a $300M goodwill impairment (non-deductible for tax). Pre-tax income before impairment was $50M. Tax rate 25%. Walk through the three-statement impact, focusing on how the valuation allowance might be adjusted and the effective tax rate. Explain whether the impairment has a cash impact.

Income Statement: Pre-tax income: $50M - $300M = ($250M) loss. Taxable income remains $50M (goodwill is non-deductible). Since taxable income is positive, the company can use NOLs to offset it. The $50M of NOL is utilized, reducing the gross DTA by $50M. Because the valuation allowance equals the gross DTA, the utilization releases $50M of valuation allowance, resulting in a deferred tax benefit of $50M × 25% = $12.5M. Current tax is zero. Total tax expense = -$12.5M (a benefit). Net loss = ($250M) - (-$12.5M) = ($237.5M). The impairment reduced net income by exactly $300M (no tax shield), and the NOL utilization reduced the loss by $12.5M. Without the impairment, net income would have been $50M + $12.5M = $62.5M.

Cash Flow Statement: Net loss ($237.5M). Add back non-cash goodwill impairment $300M. No cash taxes paid (NOLs offset taxable income, no refund because no taxes were previously paid). CFO = +$62.5M (the $300M add-back less the $237.5M loss). The impairment itself has no cash impact; the positive CFO is driven by the non-cash impairment add-back.

Balance Sheet: Assets: Goodwill -$300M. DTA: gross DTA falls by $50M (used), valuation allowance falls by $50M (released), so net DTA remains $0. Cash increases by $62.5M. Liabilities unchanged. Equity: retained earnings falls by $237.5M (net loss). Balanced.

Valuation allowance: The impairment, by creating a large book loss, may cause management to reassess whether future NOL utilization is probable. If the impairment signals that future profitability is doubtful, management might need to increase the valuation allowance against remaining NOLs, which would cause additional deferred tax expense and further reduce net income. In this case, the remaining NOLs are $150M (originally $200M less $50M used), so a full valuation allowance would be appropriate if realization is unlikely, but since we already have a full valuation allowance of $150M against the remaining $150M, no change.

Follow-up pressure:

• If the impairment were a $300M PP&E impairment that is tax-deductible, how would the valuation allowance and tax benefit change? Walk through the numbers.
• How would a sudden large goodwill impairment affect the company's ability to utilize its NOLs in the future? Could it trigger an increase in the valuation allowance?
• If the company had a history of issuing equity to fund losses, would you as a creditor be comfortable relying on the NOL asset for future tax savings?